157 related articles for article (PubMed ID: 10511429)
21. Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain.
Chefer SI; London ED; Koren AO; Pavlova OA; Kurian V; Kimes AS; Horti AG; Mukhin AG
Synapse; 2003 Apr; 48(1):25-34. PubMed ID: 12557269
[TBL] [Abstract][Full Text] [Related]
22. Autoradiography of 2-[18F]F-A-85380 on nicotinic acetylcholine receptors in the porcine brain in vitro.
Deuther-Conrad W; Wevers A; Becker G; Schildan A; Patt M; Sabri O; Steinbach J; Brust P
Synapse; 2006 Mar; 59(4):201-10. PubMed ID: 16385508
[TBL] [Abstract][Full Text] [Related]
23. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography.
Perry DC; Xiao Y; Nguyen HN; Musachio JL; Dávila-García MI; Kellar KJ
J Neurochem; 2002 Aug; 82(3):468-81. PubMed ID: 12153472
[TBL] [Abstract][Full Text] [Related]
24. Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380.
Valette H; Bottlaender M; Dollé F; Guenther I; Fuseau C; Coulon C; Ottaviani M; Crouzel C
J Nucl Med; 1999 Aug; 40(8):1374-80. PubMed ID: 10450691
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of a [2-pyridinyl-18F]-labelled fluoro derivative of (-)-cytisine as a candidate radioligand for brain nicotinic alpha4beta2 receptor imaging with PET.
Roger G; Lagnel B; Rouden J; Besret L; Valette H; Demphel S; Gopisetti J; Coulon C; Ottaviani M; Wrenn LA; Letchworth SR; Bohme GA; Benavides J; Lasne MC; Bottlaender M; Dollé F
Bioorg Med Chem; 2003 Dec; 11(24):5333-43. PubMed ID: 14642577
[TBL] [Abstract][Full Text] [Related]
26. PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate.
Hillmer AT; Wooten DW; Slesarev MS; Ahlers EO; Barnhart TE; Murali D; Schneider ML; Mukherjee J; Christian BT
J Nucl Med; 2012 Sep; 53(9):1471-80. PubMed ID: 22851633
[TBL] [Abstract][Full Text] [Related]
27. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.
Schmaljohann J; Gündisch D; Minnerop M; Bucerius J; Joe A; Reinhardt M; Guhlke S; Biersack HJ; Wüllner U
Nucl Med Biol; 2006 Apr; 33(3):305-9. PubMed ID: 16631078
[TBL] [Abstract][Full Text] [Related]
29. 2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans.
Kimes AS; Horti AG; London ED; Chefer SI; Contoreggi C; Ernst M; Friello P; Koren AO; Kurian V; Matochik JA; Pavlova O; Vaupel DB; Mukhin AG
FASEB J; 2003 Jul; 17(10):1331-3. PubMed ID: 12759330
[TBL] [Abstract][Full Text] [Related]
30. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
Pabreza LA; Dhawan S; Kellar KJ
Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
Flores CM; Dávila-García MI; Ulrich YM; Kellar KJ
J Neurochem; 1997 Nov; 69(5):2216-9. PubMed ID: 9349569
[TBL] [Abstract][Full Text] [Related]
32. NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.
Chefer SI; Pavlova OA; Zhang Y; Vaupel DB; Kimes AS; Horti AG; Stein E; Mukhin AG
J Neurochem; 2008 Jan; 104(2):306-15. PubMed ID: 17986233
[TBL] [Abstract][Full Text] [Related]
33. 5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors.
Mukhin AG; Gündisch D; Horti AG; Koren AO; Tamagnan G; Kimes AS; Chambers J; Vaupel DB; King SL; Picciotto MR; Innis RB; London ED
Mol Pharmacol; 2000 Mar; 57(3):642-9. PubMed ID: 10692507
[TBL] [Abstract][Full Text] [Related]
34. 6-[18F]Fluoro-A-85380: an in vivo tracer for the nicotinic acetylcholine receptor.
Scheffel U; Horti AG; Koren AO; Ravert HT; Banta JP; Finley PA; London ED; Dannals RF
Nucl Med Biol; 2000 Jan; 27(1):51-6. PubMed ID: 10755645
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.
Brašić JR; Cascella N; Kumar A; Zhou Y; Hilton J; Raymont V; Crabb A; Guevara MR; Horti AG; Wong DF
Synapse; 2012 Apr; 66(4):352-68. PubMed ID: 22169936
[TBL] [Abstract][Full Text] [Related]
36. Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.
Schmaljohann J; Minnerop M; Karwath P; Gündisch D; Falkai P; Guhlke S; Wüllner U
Appl Radiat Isot; 2004 Dec; 61(6):1235-40. PubMed ID: 15388115
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of 6-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors.
Ding Y; Liu N; Wang T; Marecek J; Garza V; Ojima I; Fowler JS
Nucl Med Biol; 2000 May; 27(4):381-9. PubMed ID: 10938474
[TBL] [Abstract][Full Text] [Related]
38. Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 to plasma proteins.
Sorger D; Becker GA; Hauber K; Schildan A; Patt M; Birkenmeier G; Otto A; Meyer P; Kluge M; Schliebs R; Sabri O
Nucl Med Biol; 2006 Oct; 33(7):899-906. PubMed ID: 17045170
[TBL] [Abstract][Full Text] [Related]
39. Characterization of [3H]cytisine binding to human brain membrane preparations.
Hall M; Zerbe L; Leonard S; Freedman R
Brain Res; 1993 Jan; 600(1):127-33. PubMed ID: 8422580
[TBL] [Abstract][Full Text] [Related]
40. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
